Roflumilast in severely ill patients with chronic obstructive pulmonary disease with frequent exacerbations: real-life outcomes

I. Alispahic (Hellerup, Denmark), R. Sørensen (Copenhagen, Denmark), J. Eklöf (Hellerup, Denmark), P. Sivapalan (Hellerup, Denmark), A. Løkke (Vejle, Denmark), N. Seersholm (Hellerup, Denmark), J. Vestergaard (Hellerup, Denmark), C. Bergsoe (Hellerup, Denmark), J. Jensen (Hellerup, Denmark), (Hellerup, Denmark)

Source: Virtual Congress 2020 – Clinical and basic pharmacology for COPD
Session: Clinical and basic pharmacology for COPD
Session type: E-poster session
Number: 178
Disease area: Airway diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
I. Alispahic (Hellerup, Denmark), R. Sørensen (Copenhagen, Denmark), J. Eklöf (Hellerup, Denmark), P. Sivapalan (Hellerup, Denmark), A. Løkke (Vejle, Denmark), N. Seersholm (Hellerup, Denmark), J. Vestergaard (Hellerup, Denmark), C. Bergsoe (Hellerup, Denmark), J. Jensen (Hellerup, Denmark), (Hellerup, Denmark). Roflumilast in severely ill patients with chronic obstructive pulmonary disease with frequent exacerbations: real-life outcomes. 178

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Real-life experience of older patients requiring NIV for exacerbations of chronic obstructive pulmonary disease
Source: Annual Congress 2009 - New trends in noninvasive ventilation for acute respiratory failure
Year: 2009

Hyperglycemia is associated with poor outcomes in patients with acute exacerbations of chronic obstructive pulmonary disease
Source: Annual Congress 2013 –COPD biomarkers
Year: 2013

Proactive integrated care improves quality of life in patients with COPD
Source: Eur Respir J 2009; 33: 1031-1038
Year: 2009



Can we predict the outcomes of treatment of patients with severe exacerbation of chronic obstructive pulmonary disease (COPD)?
Source: Eur Respir J 2001; 18: Suppl. 33, 241s
Year: 2001

Doxycycline for exacerbations of chronic obstructive pulmonary disease in outpatients: who benefits?
Source: ERJ Open Res, 6 (2) 00099-2020; 10.1183/23120541.00099-2020
Year: 2020



Opioids and adverse outcomes in elderly chronic obstructive pulmonary disease patients
Source: Eur Respir J 2016; 48: 1817
Year: 2016


Opioids and adverse outcomes in elderly chronic obstructive pulmonary disease patients
Source: Eur Respir J 2016; 48: 1818
Year: 2016


COPD exacerbations in patients with chronic obstructive pulmonary disease in general practice in Ireland
Source: Eur Respir J 2004; 24: Suppl. 48, 89s
Year: 2004

Calorie-intake in patients hospitalized for an acute COPD exacerbation
Source: Annual Congress 2007 - Nurses' involvement in the follow-up of patients with COPD and lung cancer
Year: 2007



The safety of sputum induction in patients with exacerbation of severe and very severe COPD (chronic obstructive pulmonary disease)
Source: Annual Congress 2008 - Organisation of care and management of COPD
Year: 2008


Cost analysis for inpatient therapy in elderly patients with acute exacerbations of chronic obstructive pulmonary disease
Source: Eur Respir J 2004; 24: Suppl. 48, 661s
Year: 2004

Azithromycin to prevent exacerbations of chronic obstructive pulmonary disease: a study in the real-world setting
Source: Virtual Congress 2020 – Clinical and basic pharmacology for COPD
Year: 2020


Hyperglycaemia and its association with outcomes in people admitted to hospital with acute exacerbations of chronic obstructive pulmonary disease
Source: Eur Respir J 2006; 28: Suppl. 50, 332s
Year: 2006

Bronchiectasis impact outcomes in patients with chronic obstructive pulmonary disease (COPD)
Source: Annual Congress 2008 - Microbiology and treatment of bronchiectasis and exacerbations of COPD
Year: 2008


Pulmonary rehabilitation and its effect on exacerbations and hospitalizations in patients with chronic obstructive pulmonary disease
Source: Annual Congress 2005 - Pulmonary rehabilitation: an evidence-based intervention
Year: 2005


Clinical profile and treatment of elderly patients hospitalized for acute exacerbation of chronic obstructive pulmonary disease. A comparative syudy
Source: Annual Congress 2013 –COPD mechanisms
Year: 2013

Does pulmonary rehabilitation improve mortality in patients with chronic obstructive pulmonary disease (COPD)?
Source: International Congress 2017 – Latest insights into pulmonary rehabilitation in COPD
Year: 2017

Antibiotics in the exacerbations of severe and very severe chronic obstructive pulmonary disease (COPD)
Source: Annual Congress 2008 - Microbiology and treatment of bronchiectasis and exacerbations of COPD
Year: 2008


Can roflumilast improve clinical outcomes in moderate-to-severe chronic obstructive pulmonary disease? A meta-analysis
Source: International Congress 2016 – COPD diagnosis and management
Year: 2016

Early versus late pulmonary rehabilitation on anxiety and depression in chronic obstructive pulmonary disease patients with acute exacerbations
Source: Annual Congress 2012 - The latest insights in pulmonary rehabilitation
Year: 2012